在心力衰竭患者中使用马尔科夫建模的健康状况轨迹,其中包括保存的喷射分数
Wonse Kim1, Minjae Yoon2, Jin Joo Park2
1Department of Mathematical Sciences, RIMS and AIIS, Seoul National University, Seoul, Republic of Korea; MetaEyes, Seoul, Republic of Korea.
Revista espanola de cardiologia (English ed.)
|February 6, 2026
概括
心力衰竭患者的与健康有关的生活质量与保存的喷射分数 (HFpEF) 患者是动态的. 较差的健康状况预测死亡率更高,但sacubitril/valsartan可能会改善这些患者的结果.
科学领域:
- 心脏病学 心脏病学
- 健康 结果 研究 研究 结果
- 药物经济学 药物经济学
背景情况:
- 在心力衰竭中,与健康相关的生活质量 (HRQoL) 与保存的喷射分数 (HFpEF) 对于患者管理至关重要.
- 使用堪萨斯城心肌病问卷 (KCCQ) 对HRQoL的连续评估可以提供动态的见解.
- 了解健康状态之间的过渡对于预测临床结果至关重要.
研究的目的:
- 评估连续KCCQ评估对HFpEF患者临床结果的预测价值.
- 利用多态马尔科夫模型来分析健康状态转变和死亡率.
- 研究HF治疗方法,特别是sacubitril/valsartan与valsartan对这些转变的影响.
主要方法:
- 一个对帕拉贡-HF研究的后期分析,涉及4707名患者.
- 根据KCCQ得分,患者被分为五种健康状况 (优秀,好,公平,差,死亡).
- 多状态马尔科夫模型被用来分析逗留时间,过渡概率和死亡率关联.
主要成果:
- 观察到健康状态之间的双向过渡,在极好的状态下持续时间最长.
- 随着健康状况的下降,每年死亡率显著增加,从优秀的3.1%到贫穷的15.6%.
- 虽然总体停留时间相似,但与瓦尔萨坦相比,萨库比特里尔/瓦尔萨坦在良好的健康状况下显示出更高的改善率和较低的死亡风险.
结论:
- 在HFpEF中的健康状况是动态的,表现为双向变化,停留时间不同.
- 较差的健康状况与明显更高的死亡率有关.
- 萨库比特里尔/瓦尔萨坦在改善健康状况较差的HFpEF患者的治疗结果方面显示出潜在的益处.
相关概念视频
01:29Heart Failure II: Pathophysiology
975
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
975
01:17Pathophysiology of Heart Failure
3.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.8K
01:27Heart Failure I: Introduction
924
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
924
01:22Heart Failure VI: Adjunct Therapies
368
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
368
01:22Heart Failure Drugs: Diuretics
990
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
990
01:30Heart Failure V: Medical Management
342
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
342